We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Several governors are demanding that the FDA issue guidances for generic versions of insulin and human growth hormone (HGH) in order to drive down drug costs.
Louisiana will become the first state to increase the fees pharmacists receive every time they fill Medicaid prescriptions with generic drugs, after Louisiana’s governor Kathleen Blanco signed legislation to offset federal Medicaid reimbursement cuts.
Rising prescription drug costs, especially for the uninsured, point to the need for a more vibrant generic drug market and more active state price negotiations, an activist group concluded in a recent report.
Massachusetts could become the first state to pass a law requiring licenses for pharmaceutical sales representatives, after the Massachusetts Senate passed the proposal as an amendment to the state budget May 25.
The Supreme Court’s refusal to review a case upholding a state fiduciary disclosure law has opened drug company price negotiations up to public scrutiny, which opponents say will undermine competition and raise prices.
Brand drugmakers could sell a larger range of pharmaceuticals to patients covered by Ontario’s healthcare system if the Canadian province’s government passes a bill that would increase the number of drugs covered under its prescription drug benefit.
Delivery to the federal government of the anthrax vaccine being developed by VaxGen, originally expected to occur by the end of the year, now will be pushed until at least late 2007, delivering a heavy fiscal blow to the financially struggling company, a VaxGen spokesman said.
Merck has entered into agreements to purchase both Abmaxis and GlycoFi in a move the company said will increase its presence in the growing field of biologic drugs.